| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085859A1 Wound treatment through inhibition of adenosine diphosphate ribosyl transferase |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/28/2001 | EP1027098A4 Electrically activated substance and method for making the same |
| 03/28/2001 | EP0725638B1 Treatment of laminitis |
| 03/28/2001 | EP0721330B1 Pharmaceutical composition |
| 03/28/2001 | CN1289254A Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions |
| 03/28/2001 | CN1289253A Treating atopic dermatitis with lgE antagonists |
| 03/28/2001 | CN1289252A Treatment of follicular lymphomas using inhibitors of the lymphotoxin (LT) pathway |
| 03/28/2001 | CN1288730A Slight-purgitive composition |
| 03/28/2001 | CN1063630C Surface-modified anticancer nanopartiles |
| 03/27/2001 | USRE37116 Nitrosated and nitrosylated compounds, and compositions and their use for treating respiratory disorders |
| 03/27/2001 | US6207803 Amino acid sequence of polypeptide; anticarcinogenic agents; antitumor agents; treatment of automimmune disorders, blood disorders; alzheimer's/parkinson's disease, septic shock, osteoporosis, polycystic kidney disease; viricides; diagnosis |
| 03/27/2001 | US6207799 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 03/27/2001 | US6207706 Use of COMT inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions |
| 03/27/2001 | US6207703 Mucoadministering to airways formulation comprising antifungal agent to reduce or eliminate symptoms of asthma |
| 03/27/2001 | US6207700 Aministering carboxylic acid secondary amide derivative containing indole system which is selective for inhibition of cyclooxygenase-2 for cancer therapy in warm blooded vertebrate animal |
| 03/27/2001 | US6207699 Reducing weight of a human, comprising administering synergistic combination with of l-5-hydroxytryptophan, carbidopa, and of pindolol |
| 03/27/2001 | US6207696 Compositions and methods for the prophylaxis and treatment of dysmenorrhea, endometriosis, and pre-term labor, using histidine |
| 03/27/2001 | US6207694 Pharmaceutical compositions and methods for managing scalp conditions |
| 03/27/2001 | US6207685 Inhibiting effects of exogenous neurotoxic or neurotoxinic products in warm-blooded animals by administering 2-methyl-1-(1-piperidinyl)-1-(2-thienyl)-cyclohexane in pure racemic, diastereoisomeric or enantiomeric form |
| 03/27/2001 | US6207674 Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants |
| 03/27/2001 | US6207654 Intravenously administering hydroxyethyl starch or dextran or their mixture and interferon or interleukins for treating human to prevent leakage of macromolecules from capillary endothelial junctions due to side effects of cancer, infection |
| 03/27/2001 | US6207653 Use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus |
| 03/27/2001 | US6207648 Methods of using cytochrome P450 reductase for the enhancement of P450-based anti-cancer gene therapy |
| 03/27/2001 | US6207647 Polynucleotides and polypeptides of the rat family, referred to as ?rata?; treatment of chlamydia infections |
| 03/27/2001 | US6207646 Immunostimulatory nucleic acid molecules |
| 03/27/2001 | US6207642 Member of the TNF family useful for treatment and diagnosis of disease |
| 03/27/2001 | US6207596 Disposable premoistened wipe containing an antimicrobial protease inhibitor |
| 03/27/2001 | US6207450 Nucleic acid of defined nucleotide sequence which encodes fkhl7 protein; drug screening; primers; probes; gene therapy; antibodies; recombinant production |
| 03/27/2001 | US6207449 Nucleotide sequence of gene; hybridization probes for detection; drug screening for bactericides, bacteriostats and antibiotics |
| 03/27/2001 | US6207412 Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells |
| 03/27/2001 | US6207401 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders |
| 03/27/2001 | US6207195 Sodium 4-phenylbutyrate in solid nanosphere formed by coacervation of a polycation, i.e., a protein and a polyanion, i.e., a nucleic acid; treatment of cystic fibrosis |
| 03/27/2001 | US6207183 Transdermal administering |
| 03/27/2001 | US6207162 AspS from Chlamydia trachomatis |
| 03/27/2001 | US6207153 Antigen binding polypeptide |
| 03/27/2001 | US6207152 Anticancer agent |
| 03/27/2001 | US6207133 Anti-tumoral therapy agent containing a contrast agent |
| 03/27/2001 | CA2214399C Soft gelatin capsule with a gelatin shell comprising xanthine derivative |
| 03/27/2001 | CA2201098C Orphan receptor |
| 03/27/2001 | CA2007499C Treatment methods and vaccines for stimulating an immune response |
| 03/22/2001 | WO2001020327A1 Spa in a screening method for modulators of glucokinase |
| 03/22/2001 | WO2001020038A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 03/22/2001 | WO2001020034A2 Methods and compositions for the screening of cell cycle modulators |
| 03/22/2001 | WO2001020031A2 Polymorphisms in a klotho gene |
| 03/22/2001 | WO2001020026A2 POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 03/22/2001 | WO2001020025A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 03/22/2001 | WO2001020018A2 Diagnosing and treating arthritic disorders |
| 03/22/2001 | WO2001020004A2 Protein phosphatase and kinase proteins |
| 03/22/2001 | WO2001019983A1 Human g-protein coupled receptor |
| 03/22/2001 | WO2001019973A2 Nicotinic acetylcholine receptor: alpha10 subunit |
| 03/22/2001 | WO2001019871A2 Delivery system for antidandruff agent |
| 03/22/2001 | WO2001019860A2 Proteins associated with cell differentiation |
| 03/22/2001 | WO2001019830A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 03/22/2001 | WO2001019819A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | WO2001019814A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | WO2001019780A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 03/22/2001 | WO2001019778A1 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/22/2001 | WO2001019776A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 03/22/2001 | WO2001019542A1 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 03/22/2001 | WO2001019407A2 Taxane prodrugs |
| 03/22/2001 | WO2001019403A1 Liposomal mixture of local anesthetics and manufacturing method thereof |
| 03/22/2001 | WO2001019399A2 Method of potentiating chemotherapy and treating solid tumors |
| 03/22/2001 | WO2001019396A1 Therapies for chronic renal failure using one or more integrin antagonists |
| 03/22/2001 | WO2001019392A1 Combination of c1-inh and lung surfactant for the treatment of respiratory disorders |
| 03/22/2001 | WO2001019390A1 Combination treatment with il-1ra and diaryl sulphonyl urea compounds |
| 03/22/2001 | WO2001019378A2 Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols |
| 03/22/2001 | WO2001019373A2 Methods and compositions for modulating responsiveness to corticosteroids |
| 03/22/2001 | WO2001019372A1 Formulations for parenteral use of estramustine phosphate and amino acids |
| 03/22/2001 | WO2001019371A1 TREATMENT OF MOVEMENT DISORDERS BY ADMINISTRATION OF 5-HYDROXYTRYPTAMINE RECEPTOR/α2 ADRENERGIC RECEPTOR ANTAGONIST COMPOSITIONS |
| 03/22/2001 | WO2001019367A1 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 03/22/2001 | WO2001019366A1 Topical treatment for prevention of ocular infections |
| 03/22/2001 | WO2001019360A2 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| 03/22/2001 | WO2001019357A2 Combination preparation for the treatment of sexual dysfunction |
| 03/22/2001 | WO2001019354A2 Composition for ivf |
| 03/22/2001 | WO2001019353A2 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth |
| 03/22/2001 | WO2001019347A1 Vascular coating composition |
| 03/22/2001 | WO2001019341A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 03/22/2001 | WO2001019340A1 Dispersion formulations containing lipase inhibitors |
| 03/22/2001 | WO2001019339A1 Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins |
| 03/22/2001 | WO2001019322A2 Use of csaids in rhinovirus infection |
| 03/22/2001 | WO2001019320A2 Phospholipid prodrugs of anti-proliferative drugs |
| 03/22/2001 | WO2001001749A3 FVIIa ANTAGONISTS |
| 03/22/2001 | WO2000073323A3 Adam polynucleotides and polypeptides |
| 03/22/2001 | WO2000069255A8 Anti-inflammatory therapy for inflammatory mediated infection |
| 03/22/2001 | WO2000055318A3 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 03/22/2001 | WO2000035469A9 hCG THERAPY FOR THE TREATMENT OF BREAST CANCER |
| 03/22/2001 | WO2000035435A9 Use of a mek inhibitor for preventing transplant rejection |
| 03/22/2001 | WO2000001376A3 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/22/2001 | WO1999058678A9 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 03/22/2001 | DE19944404A1 Mittel zur Therapie von menschlichen Erkrankungen, insbesondere für die Therapie von Tumoren wie Kolonkarzinomen und Melanomen oder zur Geweberegeneration und Förderung des Haarwuchses Means for therapy of human disease, in particular for the treatment of tumors such as colon carcinoma and melanoma, or for tissue regeneration and promote hair growth |
| 03/22/2001 | DE19944161A1 Neue Kombination zur Behandlung von sexueller Dysfunktion New combination for the treatment of sexual dysfunction |
| 03/22/2001 | CA2388383A1 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth |
| 03/22/2001 | CA2386583A1 Novel combination for the treatment of sexual dysfunction |
| 03/22/2001 | CA2386525A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 03/22/2001 | CA2385722A1 Use of csaids in rhinovirus infection |
| 03/22/2001 | CA2385065A1 Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins |
| 03/22/2001 | CA2384861A1 Combination of c1-inh and lung surfactant for the treatment of respiratory disorders |